Press Releases Year None2020201920182017201620152014201320122011201020092008 Feb 24, 2020 Concert Pharmaceuticals Selected for Late-Breaking Oral Presentation of CTP-543 Phase 2 Data in Alopecia Areata at the 2020 American Academy of Dermatology Annual Meeting Feb 20, 2020 Concert Pharmaceuticals to Report Full Year 2019 Results on February 27, 2020 Jan 30, 2020 Concert Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Jan 28, 2020 Concert Pharmaceuticals Announces Pricing of Public Offering Jan 27, 2020 Concert Pharmaceuticals Announces Proposed Public Offering of Common Stock Jan 27, 2020 Concert Pharmaceuticals Announces Federal Circuit Granted its Motion to Vacate and Remand PTAB Decision Involving CTP-543 Jan 22, 2020 Concert Pharmaceuticals Announces Notice of Allowance for U.S. Patent Application Related to CTP-543, Lead Candidate for Treatment of Alopecia Areata Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Displaying 11 - 17 of 17
Feb 24, 2020 Concert Pharmaceuticals Selected for Late-Breaking Oral Presentation of CTP-543 Phase 2 Data in Alopecia Areata at the 2020 American Academy of Dermatology Annual Meeting
Jan 30, 2020 Concert Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jan 27, 2020 Concert Pharmaceuticals Announces Federal Circuit Granted its Motion to Vacate and Remand PTAB Decision Involving CTP-543
Jan 22, 2020 Concert Pharmaceuticals Announces Notice of Allowance for U.S. Patent Application Related to CTP-543, Lead Candidate for Treatment of Alopecia Areata
